Study: Most Women with Breast Cancer Do Not Benefit from Chemo
Genomic Health, Inc. today announced that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of...
Genomic Health, Inc. today announced that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of...
By Antiste Publishing, Special for USDR In 2007, not long after fulfilling her dream of living in Paris, France, Karla...
By Centers for Disease Control and Prevention, Special for USDR Breast cancer death rates among women decreased during 2010-2014, but racial...
By Fabletics, Special for USDR The Council of Fashion Designers of America (CFDA) is partnering with the stylish, high-quality and accessible...